Nothing to disclose. Author Roles: Mohammed T. Ahmad was involved in the writing of the first draft, patient assessment, followup, and video filming. Kumar M. Prakash was involved in review and critique, writing of the final draft, patient and video assessment, and video editing.
Reversible withdrawal dyskinesia associated with quetiapine
โ Scribed by Costas Michaelides; Manisha Thakore-James; Raymon Durso
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 70 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Age, sex, race, cognitive impairment, level of depression, psychiatric diagnosis and length of time receiving neuroleptic medication have been proposed as risk factors for the development of tardive dyskinesia (TD) in the elderly. The charts of 186 patients were reviewed to collect demographic, diag
Subcutaneous infusion of apomorphine for 12 hours per day is an effective means of controlling on-off fluctuations and dyskinesias in patients with advanced Parkinson's disease (PD) resistant to other treatment. 1,2 However, this technique requires reinsertion of the injection needle into the skin o
## 359 indomethacin treatment (26.0 5 15.6%; P < 0.005). When PBL were obtained from the patient during periods of medication or from the healthy control, in vitro addition of indomethacin did not cause a significant change in generation of Con A-SC. These data showing that the reduced generation